(Q41191925)

English

The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

scientific article published on June 1996

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

1 reference

ChEBI release 2020-05-28

author name string

Berkhout TA

1

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Simon HM

2

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Patel DD

3

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Bentzen C

4

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Niesor E

5

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Jackson B

6

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Suckling KE

7

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

language of work or name

0 references

publication date

1 June 1996

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

271

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

14376-14382

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

Mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase function in alpha-toxin-perforated cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

Treatment of CHO-K1 cells with 25-hydroxycholesterol produces a more rapid loss of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity than can be accounted for by enzyme turnover

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

The effect of (-)-hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line Hep G2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

Co-ordinate regulation of low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase and synthase gene expression in HepG2 cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

Regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA contents in human hepatoma cell line Hep G2 by distinct classes of mevalonate-derived metabolites

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

Modulation of the enzymic activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by multiple kinase systems involving reversible phosphorylation: a review

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis in Syrian hamster C100 cells by mevinolin, 25-hydroxycholesterol, and mevalonate: the role of posttranscriptional control

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

Irreversible inactivation of 3-hydroxy-3-methylglutaryl-CoA reductase by H2O2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

Low-density-lipoprotein-receptor mRNA content of fibroblasts from normal and familial hypercholesterolaemic subjects

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

19 Receptor-mediated endocytosis of low-density lipoprotein in cultured cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

Phosphorylation and inactivation of HMG-CoA reductase at the AMP-activated protein kinase site in response to fructose treatment of isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

The effect of inhibitors of free radical generating-enzymes on low-density lipoprotein oxidation by macrophages

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.24.14376

21 January 2018

Identifiers

10.1074/JBC.271.24.14376

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41191925&oldid=2269818112"